| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Elkins David V EVP, Chief Financial Officer | Sale | -30,000 | -15.85%159,248 | $61.67 | $1,850,016 | View SEC filing | |
| 2025-09-03 | Elkins David V EVP, Chief Financial Officer | Sale | -56,000 | -25.07%167,379 | $47.33 | $2,650,480 | View SEC filing | |
| 2025-08-05 | Short Bartie Wendy EVP, Corporate Affairs | Sale | -378 | -6.94%5,066 | $44.23 | $16,719 | View SEC filing | |
| 2025-05-13 | Hickey Benjamin President, RayzeBio Org. | Sale | -97.391 | -100.00%0 | $38.01 | $3,702 | View SEC filing | |
| 2025-04-29 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +4,250 | +5.36%83,513.486 | $47.58 | $202,215 | View SEC filing | |
| 2025-02-21 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +2,000 | +1.95%104,626 | $55.05 | $110,096 | View SEC filing | |
| 2025-02-19 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +1,823.486 | +2.94%63,932.486 | $54.84 | $100,000 | View SEC filing | |
| 2024-11-05 | Holzer Phil M SVP and Controller | Sale | -700 | -5.62%11,760 | $55.62 | $38,931 | View SEC filing | |
| 2024-11-05 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Purchase | +1,830 | +3.04%62,109 | $54.67 | $100,055 | View SEC filing | |
| 2023-12-07 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +2,000 | +2.48%82,672 | $49.78 | $99,560 | View SEC filing | |
| 2023-11-30 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +3,071 | +4.02%79,384 | $48.86 | $150,049 | View SEC filing | |
| 2023-11-21 | Samuels Theodore R. II Director | Purchase | +8,500 | +31.48%35,500 | $49.81 | $423,385 | View SEC filing | |
| 2023-08-28 | Powell Ann EVP, Chief Human Resources | Sale | -17,986 | -39.22%27,868.088 | $61.25 | $1,101,643 | View SEC filing | |
| 2023-08-07 | Plenge Robert M EVP, Chief Research Officer | Sale | -732 | -10.01%6,584 | $61.14 | $44,754 | View SEC filing | |
| 2023-05-04 | VESSEY RUPERT EVP & President, Research | Sale | -50,385 | -51.34%47,751 | $67.06 | $3,378,818 | View SEC filing | |
| 2023-02-08 | Caforio Giovanni Board Chair and CEO | Sale | -240,000 | -50.41%236,104.333 | $74.65 | $17,916,000 | View SEC filing | |
| 2023-02-08 | Powell Ann EVP, Chief Human Resources | Sale | -11,183 | -32.67%23,043.088 | $74.69 | $835,258 | View SEC filing | |
| 2022-11-14 | Powell Ann EVP, Chief Human Resources | Sale | -16,250 | -32.19%34,226.088 | $80.45 | $1,307,313 | View SEC filing | |
| 2022-11-09 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | -45,910 | -44.58%57,079 | $78.88 | $3,621,381 | View SEC filing | |
| 2022-09-22 | Caforio Giovanni Board Chair and CEO | Sale | -25,000 | -4.99%476,104.333 | $69.71 | $1,742,750 | View SEC filing | |
| 2022-09-16 | Caforio Giovanni Board Chair and CEO | Sale | -50,000 | -9.07%501,104.333 | $71.84 | $3,592,000 | View SEC filing | |
| 2022-09-15 | Elkins David V EVP, Chief Financial Officer | Sale | -133,951 | -8.18%119,786 | $71.30 | $9,551,167 | View SEC filing | |
| 2022-09-15 | Powell Ann EVP, Chief Human Resources | Sale | -25,000 | -33.12%50,476.088 | $70.75 | $1,768,750 | View SEC filing | |
| 2022-06-14 | Caforio Giovanni Board Chair and CEO | Sale | -30,000 | -5.16%551,104.333 | $74.04 | $2,221,200 | View SEC filing | |
| 2022-06-07 | LEUNG SANDRA EVP, General Counsel | Sale | -65,000 | -17.40%308,627.333 | $74.89 | $4,867,850 | View SEC filing |
1-25 of 280
